ES2213707T3 - Estimulacion del crecimiento oseo con un derivado peptidico de la trombina. - Google Patents

Estimulacion del crecimiento oseo con un derivado peptidico de la trombina.

Info

Publication number
ES2213707T3
ES2213707T3 ES01954752T ES01954752T ES2213707T3 ES 2213707 T3 ES2213707 T3 ES 2213707T3 ES 01954752 T ES01954752 T ES 01954752T ES 01954752 T ES01954752 T ES 01954752T ES 2213707 T3 ES2213707 T3 ES 2213707T3
Authority
ES
Spain
Prior art keywords
stimulation
growth
oseo
thrombin
peptidic derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01954752T
Other languages
English (en)
Spanish (es)
Inventor
Darrell H Carney
Roger S Crowther
David J Simmons
Jinping Yang
William R Redin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
University of Texas at Austin
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Application granted granted Critical
Publication of ES2213707T3 publication Critical patent/ES2213707T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
ES01954752T 2000-07-19 2001-07-18 Estimulacion del crecimiento oseo con un derivado peptidico de la trombina. Expired - Lifetime ES2213707T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21930000P 2000-07-19 2000-07-19

Publications (1)

Publication Number Publication Date
ES2213707T3 true ES2213707T3 (es) 2004-09-01

Family

ID=22818711

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01954752T Expired - Lifetime ES2213707T3 (es) 2000-07-19 2001-07-18 Estimulacion del crecimiento oseo con un derivado peptidico de la trombina.

Country Status (13)

Country Link
US (3) US6914050B2 (enExample)
EP (1) EP1301196B1 (enExample)
JP (2) JP3691484B2 (enExample)
CN (1) CN100350971C (enExample)
AT (1) ATE254925T1 (enExample)
AU (2) AU2001276977B2 (enExample)
CA (1) CA2416487A1 (enExample)
DE (1) DE60101339T2 (enExample)
DK (1) DK1301196T3 (enExample)
ES (1) ES2213707T3 (enExample)
PT (1) PT1301196E (enExample)
TR (1) TR200400260T4 (enExample)
WO (1) WO2002005836A2 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5895766A (en) 1995-09-20 1999-04-20 Micron Technology, Inc. Method of forming a field effect transistor
WO1999060017A2 (en) 1998-05-18 1999-11-25 University College London Human tumour-derived polypeptide hormone phosphatonin
WO2003061690A1 (en) * 2002-01-17 2003-07-31 The Board Of Regents, The University Of Texas System Stimulation of bone growth and cartilage formation with thrombing peptide derivatives
AU2001276977B2 (en) 2000-07-19 2005-05-19 Orthologic Corp. Stimulation of bone growth with thrombin peptide derivatives
US6911425B2 (en) * 2000-08-16 2005-06-28 Acologix, Inc. Integrin binding motif containing peptides and methods of treating skeletal diseases
US7078021B2 (en) * 2000-08-16 2006-07-18 Acologix, Inc. Dental products comprising bone growth enhancing peptide
EP1539214A4 (en) * 2002-07-02 2008-01-02 Orthologic Corp Thrombin
CA2491135A1 (en) * 2002-07-02 2004-01-15 The Board Of Regents, The University Of Texas System Thrombin peptide derivative dimers
US7169405B2 (en) * 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
JP4740532B2 (ja) * 2003-09-30 2011-08-03 雪印乳業株式会社 骨形成促進及び骨吸収抑制剤
US20060286084A1 (en) * 2003-09-30 2006-12-21 Yoshikazu Morita Agent for promoting osteogenesis and/or inhibiting bone resorption
WO2005041998A1 (en) 2003-10-02 2005-05-12 Ali Sadat M Peptide for promoting healing of fractures
DK1559431T3 (da) 2003-12-31 2007-07-30 Orthologic Corp Farmaceutisk sammensætning til thrombinpeptidderivater
US7622438B1 (en) 2005-07-18 2009-11-24 Acologix, Inc. Protein formulation for promoting hard tissue formation
US8642059B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for intervertebral discs
US7771414B2 (en) * 2006-04-24 2010-08-10 Warsaw Orthopedic, Inc. Controlled release devices for therapeutic treatments of spinal discs
US8642060B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for osteal growth
US7879027B2 (en) * 2006-04-24 2011-02-01 Warsaw Orthopedic, Inc. Controlled release devices for fusion of osteal structures
AU2008209473B2 (en) 2007-01-22 2012-10-25 Orthotrophix, Inc. A peptide composition and a method of promoting cartilage formation
WO2008100567A2 (en) * 2007-02-15 2008-08-21 Orthologic Corp. Thrombin peptide derivatives for treating fractures in osteopenic patients
WO2009120304A1 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Thrombin derived peptides for smooth muscle relaxation
JP2011515471A (ja) * 2008-03-26 2011-05-19 オーソロジック コーポレイション 急性心筋梗塞を処置するための方法
US8952129B2 (en) * 2008-03-26 2015-02-10 The Board Of Regents Of The University Of Texas System Method of treating degenerative diseases
CA2722620A1 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Method of treating peripheral arterial disease
US20110319340A1 (en) * 2008-09-19 2011-12-29 The Board Of Regents, The University Of Texas System Methods for treating cancer
CN102250253A (zh) * 2010-05-17 2011-11-23 中国人民解放军军事医学科学院军事兽医研究所 一种含凝血酶片段融合肽
RU2551119C1 (ru) * 2013-11-29 2015-05-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Национальный исследовательский Томский политехнический университет" Времяпролетный спектрометр ионов
US10220078B2 (en) 2014-06-11 2019-03-05 The Board Of Regents Of The University Of Texas System Methods of using thrombin derivatives to treat medulloblastoma

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563489A (en) * 1984-02-10 1986-01-07 University Of California Biodegradable organic polymer delivery system for bone morphogenetic protein
US4637931A (en) * 1984-10-09 1987-01-20 The United States Of America As Represented By The Secretary Of The Army Polyactic-polyglycolic acid copolymer combined with decalcified freeze-dried bone for use as a bone repair material
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
JPH04279520A (ja) 1990-05-31 1992-10-05 Eisai Co Ltd 骨内部埋め込み用製剤
US5563124A (en) 1991-04-22 1996-10-08 Intermedics Orthopedics/ Denver, Inc. Osteogenic product and process
US5876452A (en) 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
TW369414B (en) 1994-09-30 1999-09-11 Yamanouchi Pharma Co Ltd Bone formation transplant
JPH1033657A (ja) 1996-07-23 1998-02-10 Dainippon Ink & Chem Inc 生体内分解性材料及びその製造方法
US6001352A (en) 1997-03-31 1999-12-14 Osteobiologics, Inc. Resurfacing cartilage defects with chondrocytes proliferated without differentiation using platelet-derived growth factor
EP0896825B1 (en) 1997-08-14 2002-07-17 Sulzer Innotec Ag Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors
AU2001276977B2 (en) * 2000-07-19 2005-05-19 Orthologic Corp. Stimulation of bone growth with thrombin peptide derivatives
DE60105772T2 (de) 2000-07-20 2006-02-16 Board of Regents, The University of Texas System, Austin Stimulation des knorpelwachstums mit agonisten des nicht-proteolytisch aktivierten thrombin rezeptors

Also Published As

Publication number Publication date
US7304035B2 (en) 2007-12-04
WO2002005836A3 (en) 2002-12-19
HK1055250A1 (en) 2004-01-02
EP1301196A2 (en) 2003-04-16
TR200400260T4 (tr) 2004-03-22
US20020128202A1 (en) 2002-09-12
PT1301196E (pt) 2004-04-30
DK1301196T3 (da) 2004-03-29
US6894027B2 (en) 2005-05-17
CN1635899A (zh) 2005-07-06
US20020182205A1 (en) 2002-12-05
ATE254925T1 (de) 2003-12-15
CA2416487A1 (en) 2002-01-24
AU7697701A (en) 2002-01-30
DE60101339T2 (de) 2004-09-09
US6914050B2 (en) 2005-07-05
CN100350971C (zh) 2007-11-28
US20050227923A1 (en) 2005-10-13
DE60101339D1 (de) 2004-01-08
WO2002005836A2 (en) 2002-01-24
JP3691484B2 (ja) 2005-09-07
AU2001276977B2 (en) 2005-05-19
EP1301196B1 (en) 2003-11-26
JP2005053894A (ja) 2005-03-03
JP2004503596A (ja) 2004-02-05

Similar Documents

Publication Publication Date Title
AR045179A1 (es) Uso de una combinacion de un inhibidor de la quinasa del receptor del factor de crecimiento epidermico y de agentes citotoxicos para el tratamiento e inhibicion del cancer
ES2171768T3 (es) Inhibidores de la resorcion osea y antagonistas de receptores de vitronectina.
PA8468401A1 (es) Compuestos para el tratamiento de la isquemia
CL2008001920A1 (es) Composicion farmaceutica que comprende un inhibidor de la pde 2, un agonista del receptor selectivo e2 y un portador; y uso en el tratamiento de fractura y/o defecto oseo (div. sol. 3179-04).
CO5011096A1 (es) Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs
AR020442A1 (es) Agonistas de 5ht2serotonergicos para el tratamiento de glaucoma
ATE264863T1 (de) 28-epirapaloge
PA8522701A1 (es) COMPUESTOS DE ACETAMIDAS BENCENICAS QUE SON ACTIVADORES DE LA GLUCOKINASA a-ACILO-Y a-HETEROATOMO-SUSTITUIDO
DE60329270D1 (de) Implantierbare medizinische vorrichtung mit doppelenergieversorgung
AR037109A1 (es) Uso de flibanserina
DK1023904T3 (da) Adjuvanser til anvendelse i vacciner
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
TR199801679T2 (xx) Osteoporoz i�in birle�tirme terapisi.
ATE333896T1 (de) Vaskularisierungsinhibitoren
CR7610A (es) Uso de derivados de thio-oxindol en el tratamiento de condiciones realcionadas con la hormona
EE200300193A (et) Asendatud bensimidasoolid, nende kasutamine ja ravim
ATE254925T1 (de) Stimulierung des knochenwachstums mit peptidderivaten von thrombin
AR016981A2 (es) Polipeptidos sinteticos
ES2190205T3 (es) Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda.
MXPA03001945A (es) Tetrahidroindazoles sustituidos con arilo y su uso como ligandos para el receptor gaba-a.
AR025330A1 (es) Combinacion de sustancias activas con clonidina
UY28007A1 (es) Tratamiento terapeutico
BR0313988A (pt) Escova de dentes e uso de uma escova de dentes
ES2195025T3 (es) Proteinas de fusion de un dominio de factor tisular-dominio de kunitz como inhibidores del factor viia.
AR041595A1 (es) Tratamiento terapeutico